What is the current Pharmacovigilance Services market size?

The Pharmacovigilance Services market size is approximately USD 5.5 billion as of 2022.

What is the expected growth forecast for the Pharmacovigilance Services market?

The market is expected to grow at a CAGR of 12.3% from 2023 to 2028.

What are the major challenges faced by the Pharmacovigilance Services market?

High costs and limited awareness hinder market growth.

Which regions are the leaders in the Pharmacovigilance Services market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Pharmacovigilance Services market?

Major players include IBM, Accenture, and Cognizant.

What are the future opportunities in the Pharmacovigilance Services market?

Emerging markets and technological advancements offer future growth opportunities.

How does technology impact the Pharmacovigilance Services market?

Artificial intelligence and machine learning enhance pharmacovigilance services.

What is the current regulatory landscape for Pharmacovigilance Services?

Stringent regulations and guidelines drive the need for pharmacovigilance services.

What is the future outlook for the Pharmacovigilance Services market?

The market is expected to witness significant growth due to increasing demand.

Pharmacovigilance Services Market Metrics & Forecast Analysis 2033

Pharmacovigilance Services by Application (Biotechnology and Pharmaceuticals, Contract Research Organization, Hospital, KPO / BPO, Healthcare Institutions, Others), by Types (Adverse Event Case Management, Aggregate Reporting, Signal Intelligence, Risk Management), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Pharmacovigilance Services Market Size | CAGR 12.1 Forecast 2033

Pharmacovigilance Services Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 107

Forecast Period: 2026 - 2033

Market Size: $8.2 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pharmacovigilance Services Market Overview

The Pharmacovigilance Services market refers to the collection, analysis, and reporting of adverse events and other safety data related to pharmaceutical products. As the Pharmacovigilance Services market size is estimated to reach $8.9 billion by 2026, the growth outlook for this industry is expected to be driven by increasing demand for market forecast and industry expansion. The scope of this market encompasses various services, including drug safety services, pharmacovigilance consulting, and regulatory affairs.

Loading chart…

The growth forecast for the Pharmacovigilance Services market is expected to be driven by a CAGR of 12.3% from 2026 to 2033, with macro drivers such as increasing regulatory requirements and advancements in technology. Key forces shaping the industry include technology shifts, regulations, and competitive intensity. The largest region for Pharmacovigilance Services is currently North America, while the fastest-growing region is Asia-Pacific. As the industry continues to evolve, it is essential for C-suite, strategic planners, and BD teams to stay informed about the latest trends and developments in the Pharmacovigilance Services market.

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.45 million
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PrimeVigilance; Quanticate; ProPharma; Parexel; Accenture; SOTERIUS; SGS; Medpace; PPD; QVigilance; Freyr Solutions; Navitas Life Sciences; MMS Holdings; Amarex; Astrix Technology Group; Cambridge Regulatory Services; CROMSOURCE; APCER Life Sciences; Pharmya; A+Science; Midas Pharma; George Clinical; Syneos Health; INPHARMATIS; Taimei Technology; Extedo; WCG Clinical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pharmacovigilance Services market is poised for significant growth, driven by increasing demand for patient safety and regulatory compliance. Understanding the market dynamics is crucial for stakeholders to navigate this complex landscape and capitalize on emerging opportunities.

Growth Drivers2 items

The escalating need for adverse event reporting and signal detection is driving the adoption of Pharmacovigilance Services, thereby contributing to the growth of the Pharmacovigilance Services market size. This is further fueled by the increasing complexity of clinical trials and the necessity for thorough safety monitoring.

Advancements in artificial intelligence and machine learning technologies are enhancing the efficiency and accuracy of pharmacovigilance processes, making these services more attractive to pharmaceutical companies and contributing to the growth forecast of the Pharmacovigilance Services market.

Restraints2 items

The high costs associated with implementing and maintaining pharmacovigilance systems are a significant barrier to entry for smaller pharmaceutical companies and contract research organizations, potentially limiting the growth of the Pharmacovigilance Services market.

The lack of standardization in pharmacovigilance regulations across different regions and countries can create confusion and compliance challenges, thereby restraining the Pharmacovigilance Services market size and growth forecast.

Opportunities2 items

The increasing outsourcing of pharmacovigilance services by pharmaceutical companies to contract research organizations presents a significant opportunity for the growth of the Pharmacovigilance Services market, as it allows these companies to leverage specialized expertise and technology.

The emerging markets in Asia-Pacific and Latin America offer untapped opportunities for pharmacovigilance service providers, driven by the growing pharmaceutical industries and increasing regulatory requirements in these regions, which is expected to contribute to the growth forecast of the Pharmacovigilance Services market.

Challenges2 items

The data quality and integrity issues in pharmacovigilance, particularly with the increasing volume of data from various sources, pose a significant challenge for service providers, affecting the overall Pharmacovigilance Services market size and growth.

The talent acquisition and retention challenges in the pharmacovigilance industry, due to the specialized nature of the work and the competitive job market, can impact the ability of service providers to deliver high-quality services, thereby influencing the growth forecast of the Pharmacovigilance Services market.

Market Segmentation

Loading chart…

The Pharmacovigilance Services market can be segmented based on Application, which refers to the various uses of pharmacovigilance services across different industries. This segmentation category contributes significantly to the overall Pharmacovigilance Services market size, as it helps to identify the specific areas where these services are most in demand. The Pharmacovigilance Services segmentation by Application includes subtypes such as [object Object],[object Object], which are crucial in understanding the market dynamics and trends.

Another key segmentation category in the Pharmacovigilance Services market is Types, which encompasses various subtypes such as [object Object],[object Object]. This category is essential in understanding the different types of pharmacovigilance services offered, including spontaneous reporting, cohort event monitoring, and electronic health record mining, among others. By analyzing the Types segmentation, market stakeholders can gain insights into the most commonly used services and identify areas for growth and development, ultimately contributing to the overall market taxonomy and Pharmacovigilance Services market size.

Pharmacovigilance Services Segmentation Breakdown12 items

Application

Biotechnology and Pharmaceuticals

Contract Research Organization

Hospital

KPO / BPO

Healthcare Institutions

Others

Types

Adverse Event Case Management

Aggregate Reporting

Signal Intelligence

Risk Management

Regional Insights

Loading chart…

The Pharmacovigilance Services market growth is expected to vary across regions, driven by factors such as adoption, policies, investments, demographics, infrastructure, and ecosystem maturity. The largest region, North America, holds a significant share of the market, driven by key drivers such as stringent regulatory requirements, high adoption of pharmacovigilance services, and presence of major pharmaceutical companies.

The fastest-growing region, Asia Pacific, is expected to drive the regional forecast due to key drivers such as increasing investments in healthcare infrastructure, growing demand for pharmacovigilance services, and expanding pharmaceutical industry. Europe is also expected to contribute significantly to the Pharmacovigilance Services market growth, driven by established pharmacovigilance regulations, high awareness of pharmacovigilance services, and presence of major contract research organizations. Latin America and Middle East & Africa are also expected to drive growth, driven by increasing adoption of pharmacovigilance services, growing pharmaceutical industry, and improving healthcare infrastructure.

Key Drivers by Region5 items

North America: stringent regulatory requirements, high adoption of pharmacovigilance services, presence of major pharmaceutical companies

Europe: established pharmacovigilance regulations, high awareness of pharmacovigilance services, presence of major contract research organizations

Asia Pacific: increasing investments in healthcare infrastructure, growing demand for pharmacovigilance services, expanding pharmaceutical industry

Latin America: increasing adoption of pharmacovigilance services, growing pharmaceutical industry, improving healthcare infrastructure

Middle East & Africa: growing demand for pharmacovigilance services, increasing investments in healthcare infrastructure, expanding pharmaceutical industry

Competitive Landscape

The Pharmacovigilance Services market is moderately consolidated, driven by a mix of global players and local companies. The Pharmacovigilance Services competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on expanding their service portfolio and strengthening their distribution networks, while local companies emphasize regional expertise and customized services.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to differentiate themselves. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

PrimeVigilance: regional expansion

Quanticate: premium pricing

ProPharma: innovation pipeline

Parexel: vertical integration

Accenture: OEM tie-ups

SOTERIUS: local manufacturing

Key Pharmacovigilance Services Companies27 items

PrimeVigilance

Quanticate

ProPharma

Parexel

Accenture

SOTERIUS

SGS

Medpace

PPD

QVigilance

Freyr Solutions

Navitas Life Sciences

MMS Holdings

Amarex

Astrix Technology Group

Cambridge Regulatory Services

CROMSOURCE

APCER Life Sciences

Pharmya

A+Science

Midas Pharma

George Clinical

Syneos Health

INPHARMATIS

Taimei Technology

Extedo

WCG Clinical

Market Ecosystem

The Pharmacovigilance Services ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, integrators, channels, and end users. Value is created and captured through the interactions and interdependencies among these stakeholders, from the supply of raw materials and components to the delivery of services to end users. A thorough value chain analysis is essential to understand the complex relationships within the Pharmacovigilance Services ecosystem.

Raw material/component suppliers — provide data and software

Technology providers — develop pharmacovigilance platforms

System integrators / EPCs — implement and customize solutions

Distributors / channel partners — facilitate service delivery

Service providers / after-sales — offer maintenance and support

End users / buyers — pharmaceutical companies and research institutions

Regulators/standards bodies — establish guidelines and compliance frameworks

The flow of value within the Pharmacovigilance Services ecosystem is influenced by control points, such as regulatory bodies and large pharmaceutical companies, which can impact the adoption of services. Dependency risks, including input constraints, standards, and approvals, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem may differ by region, with varying regulatory requirements and market conditions influencing the interactions among stakeholders.

Recent Industry Insights

The Pharmacovigilance Services industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed to enhance drug safety and efficacy, while mergers and acquisitions have led to the expansion of service portfolios. Furthermore, the launch of advanced technologies, such as artificial intelligence and machine learning, has improved the efficiency of pharmacovigilance services. Regulatory changes, including the implementation of new guidelines for adverse event reporting, have also impacted the industry. A shift in consumer trends towards personalized medicine has driven the demand for tailored pharmacovigilance services. Additionally, funding rounds and expansions have enabled companies to invest in research and development, driving innovation in the pharmacovigilance services market.

Analyst Overview

As the Lead Analyst for this study, my expert view is that the Pharmacovigilance Services market outlook presents a highly attractive opportunity, driven by the increasing need for drug safety monitoring and regulatory compliance. The competitive intensity is moderate, with key players focusing on innovation and strategic partnerships to gain market share. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is characterized by the adoption of artificial intelligence and machine learning technologies to enhance pharmacovigilance capabilities. The demand-supply balance is expected to remain stable, with growing demand for pharmacovigilance services being met by an increasing number of service providers. However, key risk factors such as regulatory changes and data privacy concerns may impact market growth.

11 items

1. Executive Summary

2. Pharmacovigilance Services Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharmacovigilance Services Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pharmacovigilance Services Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Biotechnology and Pharmaceuticals

6.1.2. Contract Research Organization

6.1.3. Hospital

6.1.4. KPO / BPO

6.1.5. Healthcare Institutions

6.1.6. Others

6.2. Global Pharmacovigilance Services Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Adverse Event Case Management

6.2.2. Aggregate Reporting

6.2.3. Signal Intelligence

6.2.4. Risk Management

6.3. Global Pharmacovigilance Services Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pharmacovigilance Services Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharmacovigilance Services Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pharmacovigilance Services Market Competition by Key Manufacturers

8.1. Global Pharmacovigilance Services Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pharmacovigilance Services: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. PrimeVigilance

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Quanticate

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ProPharma

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Parexel

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Accenture

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. SOTERIUS

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. SGS

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Medpace

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. PPD

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. QVigilance

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Freyr Solutions

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Navitas Life Sciences

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. MMS Holdings

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Amarex

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Astrix Technology Group

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Cambridge Regulatory Services

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. CROMSOURCE

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. APCER Life Sciences

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Pharmya

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. A+Science

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Midas Pharma

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. George Clinical

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Syneos Health

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

9.24. INPHARMATIS

9.24.1. Company Basic Information and Sales Area

9.24.2. Main Business/Business Overview

9.24.3. Product Portfolio

9.24.4. Financial

9.24.5. Recent Industry Insights

9.24.6. SWOT Analysis

9.25. Taimei Technology

9.25.1. Company Basic Information and Sales Area

9.25.2. Main Business/Business Overview

9.25.3. Product Portfolio

9.25.4. Financial

9.25.5. Recent Industry Insights

9.25.6. SWOT Analysis

9.26. Extedo

9.26.1. Company Basic Information and Sales Area

9.26.2. Main Business/Business Overview

9.26.3. Product Portfolio

9.26.4. Financial

9.26.5. Recent Industry Insights

9.26.6. SWOT Analysis

9.27. WCG Clinical

9.27.1. Company Basic Information and Sales Area

9.27.2. Main Business/Business Overview

9.27.3. Product Portfolio

9.27.4. Financial

9.27.5. Recent Industry Insights

9.27.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharmacovigilance Services Market

Figure 4: Global Pharmacovigilance Services Market: Drivers

Figure 5: Global Pharmacovigilance Services Market: Challenges

Figure 6: Global Pharmacovigilance Services Market: Trends

Figure 7: Global Pharmacovigilance Services Market: Opportunity

Figure 8: Global Pharmacovigilance Services Market: Restraint

Figure 9: Global Pharmacovigilance Services Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pharmacovigilance Services Market Value (USD Million) By Region

Figure 15: Global Pharmacovigilance Services Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pharmacovigilance Services Market Value (USD Million) By Region

Figure 23: Global Pharmacovigilance Services Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharmacovigilance Services Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pharmacovigilance Services Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pharmacovigilance Services Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pharmacovigilance Services Market Value (USD Million) By Region

Table 10: Global Pharmacovigilance Services Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pharmacovigilance Services Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pharmacovigilance Services Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pharmacovigilance Services Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: PrimeVigilance Basic Information And Sales Area

Table 31: PrimeVigilance. Products Portfolio

Table 32: Quanticate Basic Information And Sales Area

Table 33: Quanticate. Products Portfolio

Table 34: ProPharma Basic Information And Sales Area

Table 35: ProPharma. Products Portfolio

Table 36: Parexel Basic Information And Sales Area

Table 37: Parexel. Products Portfolio

Table 38: Accenture Basic Information And Sales Area

Table 39: Accenture. Products Portfolio

Table 40: SOTERIUS Basic Information And Sales Area

Table 41: SOTERIUS. Products Portfolio

Table 42: SGS Basic Information And Sales Area

Table 43: SGS. Products Portfolio

Table 44: Medpace Basic Information And Sales Area

Table 45: Medpace. Products Portfolio

Table 46: PPD Basic Information And Sales Area

Table 47: PPD. Products Portfolio

Table 48: QVigilance Basic Information And Sales Area

Table 49: QVigilance. Products Portfolio

Table 50: Freyr Solutions Basic Information And Sales Area

Table 51: Freyr Solutions. Products Portfolio

Table 52: Navitas Life Sciences Basic Information And Sales Area

Table 53: Navitas Life Sciences. Products Portfolio

Table 54: MMS Holdings Basic Information And Sales Area

Table 55: MMS Holdings. Products Portfolio

Table 56: Amarex Basic Information And Sales Area

Table 57: Amarex. Products Portfolio

Table 58: Astrix Technology Group Basic Information And Sales Area

Table 59: Astrix Technology Group. Products Portfolio

Table 60: Cambridge Regulatory Services Basic Information And Sales Area

Table 61: Cambridge Regulatory Services. Products Portfolio

Table 62: CROMSOURCE Basic Information And Sales Area

Table 63: CROMSOURCE. Products Portfolio

Table 64: APCER Life Sciences Basic Information And Sales Area

Table 65: APCER Life Sciences. Products Portfolio

Table 66: Pharmya Basic Information And Sales Area

Table 67: Pharmya. Products Portfolio

Table 68: A+Science Basic Information And Sales Area

Table 69: A+Science. Products Portfolio

Table 70: Midas Pharma Basic Information And Sales Area

Table 71: Midas Pharma. Products Portfolio

Table 72: George Clinical Basic Information And Sales Area

Table 73: George Clinical. Products Portfolio

Table 74: Syneos Health Basic Information And Sales Area

Table 75: Syneos Health. Products Portfolio

Table 76: INPHARMATIS Basic Information And Sales Area

Table 77: INPHARMATIS. Products Portfolio

Table 78: Taimei Technology Basic Information And Sales Area

Table 79: Taimei Technology. Products Portfolio

Table 80: Extedo Basic Information And Sales Area

Table 81: Extedo. Products Portfolio

Table 82: WCG Clinical Basic Information And Sales Area

Table 83: WCG Clinical. Products Portfolio

Table 84: Global Market Value (USD Million) (2025-2032) By Application

Table 85: Global Market Share (%) By Application (2032)

Table 86: Global Market Value (USD Million) (2025-2032) By Types

Table 87: Global Market Share (%) By Types (2032)

Table 88: Global Pharmacovigilance Services Market Value (USD Million) By Region

Table 89: Global Pharmacovigilance Services Market Share (%) By Region (2025-2032)

Table 90: North America Market Value (USD Million) (2025-2032) By Country

Table 91: North America Market Value (USD Million) (2025-2032) By Application

Table 92: North America Market Value (USD Million) (2025-2032) By Types

Table 93: Europe Market Value (USD Million) (2025-2032) By Country

Table 94: Europe Market Value (USD Million) (2025-2032) By Application

Table 95: Europe Market Value (USD Million) (2025-2032) By Types

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 99: South America Market Value (USD Million) (2025-2032) By Country

Table 100: South America Market Value (USD Million) (2025-2032) By Application

Table 101: South America Market Value (USD Million) (2025-2032) By Types

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Pharmacovigilance Services Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	8.20 million
Revenue forecast in 2033	20.45 million
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	PrimeVigilance; Quanticate; ProPharma; Parexel; Accenture; SOTERIUS; SGS; Medpace; PPD; QVigilance; Freyr Solutions; Navitas Life Sciences; MMS Holdings; Amarex; Astrix Technology Group; Cambridge Regulatory Services; CROMSOURCE; APCER Life Sciences; Pharmya; A+Science; Midas Pharma; George Clinical; Syneos Health; INPHARMATIS; Taimei Technology; Extedo; WCG Clinical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options